Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

An Infirmary Health doctor has been the first person to perform a TriClip G4 procedure in Mobile successfully and one of the ...

In a groundbreaking event for Arizona healthcare, HonorHealth Scottsdale Shea Medical Center recently became the first ...

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR). However, very few studies have explored its clinical characteristics, determinants, and ...

In this randomized controlled trial, a transcatheter tricuspid-valve replacement provided a mortality benefit compared to ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Patients with aortic/mitral/tricuspid valve disease or root/ascending aorta >40 mm were included as soon as they were diagnosed with heart valve disease. The multisociety working group defined ...